Report Detail

Other Global Exome Sequencing Market Size, Status and Forecast 2019-2025

  • RnM3369884
  • |
  • 01 May, 2019
  • |
  • Global
  • |
  • 92 Pages
  • |
  • QYResearch
  • |
  • Other

In 2018, the global Exome Sequencing market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.

This report focuses on the global Exome Sequencing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exome Sequencing development in United States, Europe and China.

The key players covered in this study
Illumina TruSeq Exome
Thermo Fisher
Roche
Angilent
Eurofins
Sengenics
Ambry
Macrogen
BGI
Novo Gene

Market segment by Type, the product can be split into
Agilent HaloPlex
Agilent SureSelect
Agilent SureSelect QXT
Illumina TruSeq Exome
Roche Nimblegen SeqCap
MYcroarray MYbaits

Market segment by Application, split into
Mendelian disease and rare syndrome gene discovery
The research of complex diseases
Mouse exome sequencing

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Exome Sequencing status, future forecast, growth opportunity, key market and key players.
To present the Exome Sequencing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Exome Sequencing are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Exome Sequencing Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Agilent HaloPlex
      • 1.4.3 Agilent SureSelect
      • 1.4.4 Agilent SureSelect QXT
      • 1.4.5 Illumina TruSeq Exome
      • 1.4.6 Roche Nimblegen SeqCap
      • 1.4.7 MYcroarray MYbaits
    • 1.5 Market by Application
      • 1.5.1 Global Exome Sequencing Market Share by Application (2014-2025)
      • 1.5.2 Mendelian disease and rare syndrome gene discovery
      • 1.5.3 The research of complex diseases
      • 1.5.4 Mouse exome sequencing
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Exome Sequencing Market Size
    • 2.2 Exome Sequencing Growth Trends by Regions
      • 2.2.1 Exome Sequencing Market Size by Regions (2014-2025)
      • 2.2.2 Exome Sequencing Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Exome Sequencing Market Size by Manufacturers
      • 3.1.1 Global Exome Sequencing Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Exome Sequencing Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Exome Sequencing Market Concentration Ratio (CR5 and HHI)
    • 3.2 Exome Sequencing Key Players Head office and Area Served
    • 3.3 Key Players Exome Sequencing Product/Solution/Service
    • 3.4 Date of Enter into Exome Sequencing Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Exome Sequencing Market Size by Type (2014-2019)
    • 4.2 Global Exome Sequencing Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Exome Sequencing Market Size (2014-2019)
    • 5.2 Exome Sequencing Key Players in United States
    • 5.3 United States Exome Sequencing Market Size by Type
    • 5.4 United States Exome Sequencing Market Size by Application

    6 Europe

    • 6.1 Europe Exome Sequencing Market Size (2014-2019)
    • 6.2 Exome Sequencing Key Players in Europe
    • 6.3 Europe Exome Sequencing Market Size by Type
    • 6.4 Europe Exome Sequencing Market Size by Application

    7 China

    • 7.1 China Exome Sequencing Market Size (2014-2019)
    • 7.2 Exome Sequencing Key Players in China
    • 7.3 China Exome Sequencing Market Size by Type
    • 7.4 China Exome Sequencing Market Size by Application

    8 Japan

    • 8.1 Japan Exome Sequencing Market Size (2014-2019)
    • 8.2 Exome Sequencing Key Players in Japan
    • 8.3 Japan Exome Sequencing Market Size by Type
    • 8.4 Japan Exome Sequencing Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Exome Sequencing Market Size (2014-2019)
    • 9.2 Exome Sequencing Key Players in Southeast Asia
    • 9.3 Southeast Asia Exome Sequencing Market Size by Type
    • 9.4 Southeast Asia Exome Sequencing Market Size by Application

    10 India

    • 10.1 India Exome Sequencing Market Size (2014-2019)
    • 10.2 Exome Sequencing Key Players in India
    • 10.3 India Exome Sequencing Market Size by Type
    • 10.4 India Exome Sequencing Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Exome Sequencing Market Size (2014-2019)
    • 11.2 Exome Sequencing Key Players in Central & South America
    • 11.3 Central & South America Exome Sequencing Market Size by Type
    • 11.4 Central & South America Exome Sequencing Market Size by Application

    12 International Players Profiles

    • 12.1 Illumina TruSeq Exome
      • 12.1.1 Illumina TruSeq Exome Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Exome Sequencing Introduction
      • 12.1.4 Illumina TruSeq Exome Revenue in Exome Sequencing Business (2014-2019)
      • 12.1.5 Illumina TruSeq Exome Recent Development
    • 12.2 Thermo Fisher
      • 12.2.1 Thermo Fisher Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Exome Sequencing Introduction
      • 12.2.4 Thermo Fisher Revenue in Exome Sequencing Business (2014-2019)
      • 12.2.5 Thermo Fisher Recent Development
    • 12.3 Roche
      • 12.3.1 Roche Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Exome Sequencing Introduction
      • 12.3.4 Roche Revenue in Exome Sequencing Business (2014-2019)
      • 12.3.5 Roche Recent Development
    • 12.4 Angilent
      • 12.4.1 Angilent Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Exome Sequencing Introduction
      • 12.4.4 Angilent Revenue in Exome Sequencing Business (2014-2019)
      • 12.4.5 Angilent Recent Development
    • 12.5 Eurofins
      • 12.5.1 Eurofins Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Exome Sequencing Introduction
      • 12.5.4 Eurofins Revenue in Exome Sequencing Business (2014-2019)
      • 12.5.5 Eurofins Recent Development
    • 12.6 Sengenics
      • 12.6.1 Sengenics Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Exome Sequencing Introduction
      • 12.6.4 Sengenics Revenue in Exome Sequencing Business (2014-2019)
      • 12.6.5 Sengenics Recent Development
    • 12.7 Ambry
      • 12.7.1 Ambry Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Exome Sequencing Introduction
      • 12.7.4 Ambry Revenue in Exome Sequencing Business (2014-2019)
      • 12.7.5 Ambry Recent Development
    • 12.8 Macrogen
      • 12.8.1 Macrogen Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Exome Sequencing Introduction
      • 12.8.4 Macrogen Revenue in Exome Sequencing Business (2014-2019)
      • 12.8.5 Macrogen Recent Development
    • 12.9 BGI
      • 12.9.1 BGI Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Exome Sequencing Introduction
      • 12.9.4 BGI Revenue in Exome Sequencing Business (2014-2019)
      • 12.9.5 BGI Recent Development
    • 12.10 Novo Gene
      • 12.10.1 Novo Gene Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Exome Sequencing Introduction
      • 12.10.4 Novo Gene Revenue in Exome Sequencing Business (2014-2019)
      • 12.10.5 Novo Gene Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Summary:
      Get latest Market Research Reports on Global Exome Sequencing . Industry analysis & Market Report on Global Exome Sequencing is a syndicated market report, published as Global Exome Sequencing Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Global Exome Sequencing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,069.30
      4,603.95
      6,138.60
      3,603.60
      5,405.40
      7,207.20
      611,871.00
      917,806.50
      1,223,742.00
      324,870.00
      487,305.00
      649,740.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report